Coronavirus, officially named Covid-19, is causing substantial changes to the daily lives of people around the world, dramatic damage to financial markets, and unfortunately, thousands of deaths. The disease is, however, causing previously unseen levels of collaboration between firms of many industries, and leading many others to release open source models for tools to help health care workers and everyday citizens alike. One industry seeing lots of collaboration is AI Biotech, as firms look for both vaccines, treatments, and diagnostic tools. Here are just a few firms doing high impact work using AI:
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.
View Patent Forecast®
Top Corporations
News and Insights
Data Visualization
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.